152 related articles for article (PubMed ID: 3149736)
21. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration.
Williamson JR; Chang K; Tilton RG; Prater C; Jeffrey JR; Weigel C; Sherman WR; Eades DM; Kilo C
Diabetes; 1987 Jul; 36(7):813-21. PubMed ID: 3108058
[TBL] [Abstract][Full Text] [Related]
22. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.
Suárez G; Rajaram R; Bhuyan KC; Oronsky AL; Goidl JA
J Clin Invest; 1988 Aug; 82(2):624-7. PubMed ID: 3136193
[TBL] [Abstract][Full Text] [Related]
23. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats.
Poulsom R; Mirrlees DJ; Earl DC; Heath H
Exp Eye Res; 1983 May; 36(5):751-60. PubMed ID: 6406254
[TBL] [Abstract][Full Text] [Related]
24. Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects.
Benedek IH; Blouin RA; McNamara PJ
Br J Clin Pharmacol; 1984 Dec; 18(6):941-6. PubMed ID: 6529534
[TBL] [Abstract][Full Text] [Related]
25. AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats.
Yen TT; Fuller RW; Broderick CL; Hemrick-Luecke SK; Perry KW
Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):257-60. PubMed ID: 3141993
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of aldehyde reductase by aldose reductase inhibitors.
Sato S; Kador PF
Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
[TBL] [Abstract][Full Text] [Related]
27. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
Funada M; Okamoto I; Fujinaga Y; Yamana T
Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
[No Abstract] [Full Text] [Related]
28. Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepam.
McNamara PJ; Trueb V; Stoeckel K
Biochem Pharmacol; 1990 Sep; 40(6):1247-53. PubMed ID: 2403378
[TBL] [Abstract][Full Text] [Related]
29. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
Price DE; Airey CM; Alani SM; Wales JK
Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
[TBL] [Abstract][Full Text] [Related]
30. Ultrastructural observations on myelinated fibres in experimental diabetes: effect of the aldose reductase inhibitor ponalrestat given alone or in conjunction with insulin therapy.
Bhoyrul S; Sharma AK; Stribling D; Mirrlees DD; Peterson RG; Farber MO; Thomas PK
J Neurol Sci; 1988 Jun; 85(2):131-47. PubMed ID: 2968441
[TBL] [Abstract][Full Text] [Related]
31. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
32. Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Edelist T; Varagiannis E
Pharmacology; 1986; 32(1):52-60. PubMed ID: 3080763
[TBL] [Abstract][Full Text] [Related]
33. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
Funada M; Okamoto I; Fujinaga Y; Yamana T
Jpn J Ophthalmol; 1987; 31(2):305-14. PubMed ID: 3118085
[TBL] [Abstract][Full Text] [Related]
34. Prevention of peripheral nerve dysfunction by an aldose reductase inhibitor in streptozotocin-diabetic rats.
Kikkawa R; Hatanaka I; Yasuda H; Kobayashi N; Shigeta Y
Metabolism; 1984 Mar; 33(3):212-4. PubMed ID: 6420645
[TBL] [Abstract][Full Text] [Related]
35. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats.
Carrington AL; Ettlinger CB; Calcutt NA; Tomlinson DR
Diabetologia; 1991 Jun; 34(6):397-401. PubMed ID: 1653157
[TBL] [Abstract][Full Text] [Related]
36. Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic rats.
Nakayama K; Murakami N; Ohta M; Kato K; Ida K; Mizota M; Miwa I; Okuda J
Eur J Pharmacol; 1995 Mar; 276(1-2):77-83. PubMed ID: 7781698
[TBL] [Abstract][Full Text] [Related]
37. The effects of long-term treatment of streptozotocin-diabetic rats with an aldose reductase inhibitor.
Poulsom R; Boot-Handford RP; Heath H
Exp Eye Res; 1983 Nov; 37(5):507-15. PubMed ID: 6423399
[TBL] [Abstract][Full Text] [Related]
38. Diabetes can alter the signal transduction pathways in the lens of rats.
Zatechka DS; Kador PF; Garcia-Castiñeiras S; Lou MF
Diabetes; 2003 Apr; 52(4):1014-22. PubMed ID: 12663474
[TBL] [Abstract][Full Text] [Related]
39. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.
Kikkawa R; Hatanaka I; Yasuda H; Kobayashi N; Shigeta Y; Terashima H; Morimura T; Tsuboshima M
Diabetologia; 1983 Apr; 24(4):290-2. PubMed ID: 6407887
[TBL] [Abstract][Full Text] [Related]
40. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
